Bykerk, Vivian Patricia

Publications

Sort by

Co-Author Network

selected publications

Can Patients With Controlled Rheumatoid Arthritis Taper Methotrexate From Targeted Therapy and Sustain Remission? A Systematic Review and Metaanalysis. The Journal of rheumatology. 2022 Review GET IT
Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update. Annals of the rheumatic diseases. 2022 Conference Paper GET IT
Times cited: 5
Canadian Rheumatology Association Living Guidelines for the Pharmacological Management of Rheumatoid Arthritis With Disease-Modifying Antirheumatic Drugs. The Journal of rheumatology. 2022 Academic Article GET IT
Times cited: 2
Sarilumab monotherapy vs sarilumab and methotrexate combination therapy in patients with rheumatoid arthritis. Rheumatology (Oxford, England). 2022 Academic Article GET IT
Modification of immunomodulatory medications by rheumatology patients during the peak of the COVID-19 pandemic in New York City. Clinical rheumatology. 2022 Letter GET IT
Predictors of Influenza Vaccination in Early Rheumatoid Arthritis 2017-2021: Results From the Canadian Early Arthritis Cohort. ACR open rheumatology. 2022 Academic Article GET IT
Times cited: 1
Identifying Minimal and Meaningful Change in a Patient-Reported Outcomes Measurement Information System for Rheumatoid Arthritis: Use of Multiple Methods and Perspectives. Arthritis care & research. 2022 Academic Article GET IT
Times cited: 9
Frequency of Symptomatic Adverse Events in Rheumatoid Arthritis: An Exploratory Online Survey. The Journal of rheumatology. 2022 Academic Article GET IT
Times cited: 3
Patient and rheumatologist perspectives on tapering DMARDs in rheumatoid arthritis: a qualitative study. Rheumatology (Oxford, England). 2022 Academic Article GET IT
Times cited: 4
Identification of Distinct Disease Activity Trajectories in Methotrexate-Naive Patients With Rheumatoid Arthritis Receiving Tofacitinib Over Twenty-Four Months. Arthritis care & research. 2022 Academic Article GET IT
Times cited: 1
Immunomodulatory and immunosuppressive medication modification among patients with rheumatic diseases at the time of COVID-19 vaccination. The Lancet. Rheumatology. 2021 Academic Article GET IT
Times cited: 4
Reply. Arthritis & rheumatology (Hoboken, N.J.). 2021 Letter GET IT
Corrigendum to: Patient and Rheumatologist Perspectives on Tapering DMARDs in Rheumatoid Arthritis: A Qualitative Study. Rheumatology (Oxford, England). 2021 Article GET IT
Times cited: 1
Adverse events and disease flares after SARS-CoV-2 vaccination in patients with systemic lupus erythematosus. Clinical rheumatology. 2021 Letter GET IT
Times cited: 6
A Bridge Too Far? Real-World Practice Patterns of Early Glucocorticoid Use in the Canadian Early Arthritis Cohort. ACR open rheumatology. 2021 Academic Article GET IT
Times cited: 1
HLA-DRB1 risk alleles for RA are associated with differential clinical responsiveness to abatacept and adalimumab: data from a head-to-head, randomized, single-blind study in autoantibody-positive early RA. Arthritis research & therapy. 2021 Academic Article GET IT
Times cited: 6
Patients and clinicians define symptom levels and meaningful change for PROMIS pain interference and fatigue in RA using bookmarking. Rheumatology (Oxford, England). 2021 Academic Article GET IT
Times cited: 9
Heterogeneity in Patient Characteristics and Differences in Treatment Across 4 Canadian Rheumatoid Arthritis Cohorts. The Journal of rheumatology. 2021 Academic Article GET IT
Associations Between Safety of Certolizumab Pegol, Disease Activity, and Patient Characteristics, Including Corticosteroid Use and Body Mass Index. ACR open rheumatology. 2021 Academic Article GET IT
Times cited: 2
Pregnancy and Rheumatic Disease: Experience at a Single Center in New York City During the COVID-19 Pandemic. Arthritis care & research. 2021 Academic Article GET IT
Times cited: 3
Systemic rheumatic disease flares after SARS-CoV-2 vaccination among rheumatology outpatients in New York City. Annals of the rheumatic diseases. 2021 Letter GET IT
Times cited: 48
A Population-Based Approach to Reporting System-Level Performance Measures for Rheumatoid Arthritis Care. Arthritis care & research. 2021 Academic Article GET IT
Times cited: 12
Etanercept or Methotrexate Withdrawal in Rheumatoid Arthritis Patients in Sustained Remission. Arthritis & rheumatology (Hoboken, N.J.). 2021 Academic Article GET IT
Times cited: 27
Data-Driven Patient Clustering and Differential Clinical Outcomes in the Brigham and Women's Rheumatoid Arthritis Sequential Study Registry. Arthritis care & research. 2021 Academic Article GET IT
Times cited: 4
Health Assessment Questionnaire at One Year Predicts All-Cause Mortality in Patients With Early Rheumatoid Arthritis. Arthritis & rheumatology (Hoboken, N.J.). 2020 Academic Article GET IT
Times cited: 11
Reply. Arthritis & rheumatology (Hoboken, N.J.). 2020 Letter GET IT
Improvements in Fatigue Lag Behind Disease Remission in Early Rheumatoid Arthritis: Results From the Canadian Early Arthritis Cohort. Arthritis & rheumatology (Hoboken, N.J.). 2020 Academic Article GET IT
Times cited: 9
Reply. Arthritis & rheumatology (Hoboken, N.J.). 2020 Letter GET IT
What Does the Patient Global Health Assessment in Rheumatoid Arthritis Really Tell Us? Contribution of Specific Dimensions of Health-Related Quality of Life. Arthritis care & research. 2020 Academic Article GET IT
Times cited: 7
The efficacy and safety of targeting GM-CSF in arthritis. The Lancet. Rheumatology. 2020 Academic Article GET IT
Times cited: 10
Higher Checkpoint Inhibitor Arthritis Disease Activity may be Associated With Cancer Progression: Results From an Observational Registry. ACR open rheumatology. 2020 Academic Article GET IT
Times cited: 6
Evaluating Quality of Care for Rheumatoid Arthritis for the Population of Alberta Using System-level Performance Measures. The Journal of rheumatology. 2020 Academic Article GET IT
Times cited: 7
Treatment Strategies in Early Rheumatoid Arthritis Methotrexate Management: Results From a Prospective Cohort. Arthritis care & research. 2020 Academic Article GET IT
Times cited: 8
Using a Discrete-Choice Experiment in a Decision Aid to Nudge Patients Towards Value-Concordant Treatment Choices in Rheumatoid Arthritis: A Proof-of-Concept Study. Patient preference and adherence. 2020 Academic Article GET IT
Times cited: 11
Rheumatoid Arthritis Flares After Total Hip and Total Knee Arthroplasty: Outcomes at One Year. Arthritis care & research. 2020 Academic Article GET IT
Times cited: 14
Disruptive innovation in rheumatology: new networks of global public-private partnerships are needed to take advantage of scientific progress. Annals of the rheumatic diseases. 2020 Review GET IT
Times cited: 1
A Call to Systematically Monitor for Adverse Events in Users of Low-Dose Methotrexate Therapy. Annals of internal medicine. 2020 Academic Article GET IT
Times cited: 3
Rheumatoid Arthritis Morning Stiffness Is Associated With Synovial Fibrin and Neutrophils. Arthritis & rheumatology (Hoboken, N.J.). 2020 Academic Article GET IT
Times cited: 14
A quarter of patients time their early rheumatoid arthritis onset differently than physicians. RMD open. 2019 Academic Article GET IT
Unmet need in rheumatology: reports from the Targeted Therapies meeting 2019. Annals of the rheumatic diseases. 2019 Review GET IT
Times cited: 41
Palindromic Rheumatism Frequently Precedes Early Rheumatoid Arthritis: Results From an Incident Cohort. ACR open rheumatology. 2019 Academic Article GET IT
Times cited: 39
Prevalence and Characteristics of Metabolic Syndrome Differ in Men and Women with Early Rheumatoid Arthritis. ACR open rheumatology. 2019 Academic Article GET IT
Times cited: 6
Testing population-based performance measures identifies gaps in juvenile idiopathic arthritis (JIA) care. BMC health services research. 2019 Academic Article GET IT
Times cited: 5
Joint Estimation of Remission and Response for Methotrexate-Based DMARD Options in Rheumatoid Arthritis: A Bivariate Network Meta-Analysis. ACR open rheumatology. 2019 Academic Article GET IT
Times cited: 1
Correlates of Successful Rheumatoid Arthritis Flare Management: Clinician-driven Treatment, Home-based Strategies, and Medication Change. The Journal of rheumatology. 2019 Academic Article GET IT
Times cited: 3
Histologic and Transcriptional Evidence of Subclinical Synovial Inflammation in Patients With Rheumatoid Arthritis in Clinical Remission. Arthritis & rheumatology (Hoboken, N.J.). 2019 Academic Article GET IT
Times cited: 16
Long-term safety of certolizumab pegol in rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, psoriasis and Crohn's disease: a pooled analysis of 11 317 patients across clinical trials. RMD open. 2019 Academic Article GET IT
Times cited: 72
HBEGF⁺ macrophages in rheumatoid arthritis induce fibroblast invasiveness. Science translational medicine. 2019 Academic Article GET IT
Times cited: 102
Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry. Nature immunology. 2019 Academic Article GET IT
Times cited: 529
Correction to: On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritis. Rheumatology international. 2019 Academic Article GET IT
Patient-Reported Outcomes Measurement Information System Versus Legacy Instruments: Are They Ready for Prime Time?. Rheumatic diseases clinics of North America. 2019 Review GET IT
Times cited: 7
Long-term safety and effectiveness of tocilizumab in patients with rheumatoid arthritis and inadequate responses to csDMARDs and/or TNF inhibitors: an open-label study close to clinical practice. Clinical rheumatology. 2019 Academic Article GET IT
Times cited: 4
Pragmaticism of Randomized Controlled Trials of Biologic Treatment With Methotrexate in Rheumatoid Arthritis: A Systematic Review. Arthritis care & research. 2019 Academic Article GET IT
Times cited: 12
Low-dose Glucocorticoid Use Does Not Reduce Biologic Use in Early RA, Nor Do Biologics Reduce the Need for Glucocorticoids. The Journal of rheumatology. 2019 Editorial Article GET IT
Times cited: 1
Association of Arthritis Onset with Influenza: Analysis of the Canadian Early Inflammatory Arthritis Cohort. ACR open rheumatology. 2019 Academic Article GET IT
Times cited: 2
PROMIS Fatigue short forms are reliable and valid in adults with rheumatoid arthritis. Journal of patient-reported outcomes. 2019 Academic Article GET IT
Times cited: 52
Adaptive Trial Designs in Rheumatology: Report from the OMERACT Special Interest Group. The Journal of rheumatology. 2019 Academic Article GET IT
Times cited: 5
Patient Perspectives on DMARD Safety Concerns in Rheumatology Trials: Results from Inflammatory Arthritis Patient Focus Groups and OMERACT Attendees Discussion. The Journal of rheumatology. 2019 Academic Article GET IT
Times cited: 6
Re-treatment with abatacept plus methotrexate for disease flare after complete treatment withdrawal in patients with early rheumatoid arthritis: 2-year results from the AVERT study. RMD open. 2019 Academic Article GET IT
Times cited: 111
Unmet need in rheumatology: reports from the Targeted Therapies meeting 2018. Annals of the rheumatic diseases. 2019 Review GET IT
Times cited: 18
On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritis. Rheumatology international. 2018 Academic Article GET IT
Times cited: 4
Mixed-effects association of single cells identifies an expanded effector CD4⁺ T cell subset in rheumatoid arthritis. Science translational medicine. 2018 Academic Article GET IT
Times cited: 71
Early Rheumatoid Arthritis Presentation, Treatment, and Outcomes in Aboriginal Patients in Canada: A Canadian Early Arthritis Cohort Study Analysis. Arthritis care & research. 2018 Academic Article GET IT
Times cited: 15
Overweight, Obesity, and the Likelihood of Achieving Sustained Remission in Early Rheumatoid Arthritis: Results From a Multicenter Prospective Cohort Study. Arthritis care & research. 2018 Academic Article GET IT
Times cited: 29
Methods for high-dimensional analysis of cells dissociated from cryopreserved synovial tissue. Arthritis research & therapy. 2018 Academic Article GET IT
Times cited: 64
Feasibility of Measurement and Adherence to System Performance Measures for Rheumatoid Arthritis in 5 Models of Care. The Journal of rheumatology. 2018 Academic Article GET IT
Times cited: 13
Combining online and in-person methods to evaluate the content validity of PROMIS fatigue short forms in rheumatoid arthritis. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. 2018 Academic Article GET IT
Times cited: 16
Identification of Three Rheumatoid Arthritis Disease Subtypes by Machine Learning Integration of Synovial Histologic Features and RNA Sequencing Data. Arthritis & rheumatology (Hoboken, N.J.). 2018 Academic Article GET IT
Times cited: 108
High Adherence to System-Level Performance Measures for Rheumatoid Arthritis in a National Early Arthritis Cohort Over Eight Years. Arthritis care & research. 2018 Academic Article GET IT
Times cited: 10
Rheumatoid arthritis: Moving towards IMPROVED drug-free remission. Nature reviews. Rheumatology. 2018 Comment GET IT
Flares in Patients with Rheumatoid Arthritis after Total Hip and Total Knee Arthroplasty: Rates, Characteristics, and Risk Factors. The Journal of rheumatology. 2018 Academic Article GET IT
Times cited: 32
Functionally distinct disease-associated fibroblast subsets in rheumatoid arthritis. Nature communications. 2018 Academic Article GET IT
Times cited: 279
Single-cell RNA-seq of rheumatoid arthritis synovial tissue using low-cost microfluidic instrumentation. Nature communications. 2018 Academic Article GET IT
Times cited: 197
A comparison of health-related quality of life (HRQoL) across four systemic autoimmune rheumatic diseases (SARDs). PloS one. 2017 Academic Article GET IT
Times cited: 15
Corrigendum to "Klinefelter's syndrome (47,XXY) is in excess among men with Sjögren's syndrome" [Clin. Immunol. 168 (2016) 25-29]. Clinical immunology (Orlando, Fla.). 2017 Academic Article GET IT
Times cited: 1
Rare X Chromosome Abnormalities in Systemic Lupus Erythematosus and Sjögren's Syndrome. Arthritis & rheumatology (Hoboken, N.J.). 2017 Academic Article GET IT
Times cited: 34
A Phase III Study Evaluating Continuation, Tapering, and Withdrawal of Certolizumab Pegol After One Year of Therapy in Patients With Early Rheumatoid Arthritis. Arthritis & rheumatology (Hoboken, N.J.). 2017 Academic Article GET IT
Times cited: 22
Content and Construct Validity, Reliability, and Responsiveness of the Rheumatoid Arthritis Flare Questionnaire: OMERACT 2016 Workshop Report. The Journal of rheumatology. 2017 Academic Article GET IT
Times cited: 20
The effect of rheumatoid arthritis-associated autoantibodies on the incidence of cardiovascular events in a large inception cohort of early inflammatory arthritis. Rheumatology (Oxford, England). 2017 Academic Article GET IT
Times cited: 20
Predicting Low Disease State and Remission in Early Rheumatoid Arthritis in the First Six Months, Comparing the Simplified Disease Activity Index and European League Against Rheumatism Response Measures: Results From an Early Arthritis Cohort. Arthritis care & research. 2017 Academic Article GET IT
Times cited: 2
Thresholds for the 28-joint disease activity score (DAS28) using C-reactive protein are lower compared to DAS28 using erythrocyte sedimentation rate in early rheumatoid arthritis. Clinical and experimental rheumatology. 2017 Academic Article GET IT
Times cited: 7
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Annals of the rheumatic diseases. 2017 Review GET IT
Times cited: 1860
Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis. Nature. 2017 Academic Article GET IT
Times cited: 572
Targeting the RhoA-ROCK pathway to reverse T-cell dysfunction in SLE. Annals of the rheumatic diseases. 2016 Academic Article GET IT
Times cited: 62
Adherence and Persistence with Methotrexate in Rheumatoid Arthritis: A Systematic Review. The Journal of rheumatology. 2016 Review GET IT
Times cited: 69
Response to: 'Let's stop fooling ourselves. In RA, only ACR/EULAR criteria define remission and equate with absence of disease!' by Boers. Annals of the rheumatic diseases. 2016 Letter GET IT
Times cited: 1
Treatment preferences of patients with early rheumatoid arthritis: a discrete-choice experiment. Rheumatology (Oxford, England). 2016 Academic Article GET IT
Times cited: 51
Self-reported comorbidity is common in early inflammatory arthritis and associated with poorer function and worse arthritis disease outcomes: results from the Canadian Early Arthritis Cohort. Rheumatology (Oxford, England). 2016 Academic Article GET IT
Times cited: 25
Identifying flares in rheumatoid arthritis: reliability and construct validation of the OMERACT RA Flare Core Domain Set. RMD open. 2016 Academic Article GET IT
Times cited: 263
Certolizumab pegol in combination with dose-optimised methotrexate in DMARD-naïve patients with early, active rheumatoid arthritis with poor prognostic factors: 1-year results from C-EARLY, a randomised, double-blind, placebo-controlled phase III study. Annals of the rheumatic diseases. 2016 Academic Article GET IT
Times cited: 70
X Chromosome Dose and Sex Bias in Autoimmune Diseases: Increased Prevalence of 47,XXX in Systemic Lupus Erythematosus and Sjögren's Syndrome. Arthritis & rheumatology (Hoboken, N.J.). 2016 Academic Article GET IT
Times cited: 96
Klinefelter's syndrome (47,XXY) is in excess among men with Sjögren's syndrome. Clinical immunology (Orlando, Fla.). 2016 Academic Article GET IT
Times cited: 59
Reduction in Serum Uric Acid May Be Related to Methotrexate Efficacy in Early Rheumatoid Arthritis: Data from the Canadian Early Arthritis Cohort (CATCH). Clinical medicine insights. Arthritis and musculoskeletal disorders. 2016 Academic Article GET IT
Times cited: 13
Sustained improvements in MRI outcomes with abatacept following the withdrawal of all treatments in patients with early, progressive rheumatoid arthritis. Annals of the rheumatic diseases. 2016 Academic Article GET IT
Times cited: 17
Management of perioperative tumour necrosis factor α inhibitors in rheumatoid arthritis patients undergoing arthroplasty: a systematic review and meta-analysis. Rheumatology (Oxford, England). 2015 Review GET IT
Times cited: 68
Determining the Minimally Important Difference in the Clinical Disease Activity Index for Improvement and Worsening in Early Rheumatoid Arthritis Patients. Arthritis care & research. 2015 Academic Article GET IT
Times cited: 64
Missing Anticitrullinated Protein Antibody Does Not Affect Short-term Outcomes in Early Inflammatory Arthritis: From the Canadian Early Arthritis Cohort. The Journal of rheumatology. 2015 Academic Article GET IT
Times cited: 6
Heterogeneous Disease Trajectories Explain Variable Radiographic, Function and Quality of Life Outcomes in the Canadian Early Arthritis Cohort (CATCH). PloS one. 2015 Academic Article GET IT
Times cited: 29
14-3-3η Autoantibodies: Diagnostic Use in Early Rheumatoid Arthritis. The Journal of rheumatology. 2015 Academic Article GET IT
Times cited: 26
Erratum to: Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice. Clinical rheumatology. 2015 Article GET IT
Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update. Annals of the rheumatic diseases. 2015 Review GET IT
Times cited: 181
The comparative effectiveness of oral versus subcutaneous methotrexate for the treatment of early rheumatoid arthritis. Annals of the rheumatic diseases. 2015 Academic Article GET IT
Times cited: 61
Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. Annals of the rheumatic diseases. 2015 Conference Paper GET IT
Times cited: 956
Effect of age at menopause on disease presentation in early rheumatoid arthritis: results from the Canadian Early Arthritis Cohort. Arthritis care & research. 2015 Academic Article GET IT
Times cited: 20
More than Just Minutes of Stiffness in the Morning: Report from the OMERACT Rheumatoid Arthritis Flare Group Stiffness Breakout Sessions. The Journal of rheumatology. 2015 Review GET IT
Times cited: 16
Feasibility and Domain Validation of Rheumatoid Arthritis (RA) Flare Core Domain Set: Report of the OMERACT 2014 RA Flare Group Plenary. The Journal of rheumatology. 2015 Review GET IT
Times cited: 39
Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice. Clinical rheumatology. 2015 Academic Article GET IT
Times cited: 31
Outcomes related to methotrexate dose and route of administration in patients with rheumatoid arthritis: a systematic literature review. Clinical and experimental rheumatology. 2014 Review GET IT
Times cited: 43
Radiographic progression in rheumatoid arthritis: does it still happen and does it matter?. The Journal of rheumatology. 2014 Editorial Article GET IT
Does socioeconomic status affect outcomes in early inflammatory arthritis? Data from a canadian multisite suspected rheumatoid arthritis inception cohort. The Journal of rheumatology. 2014 Academic Article GET IT
Times cited: 21
Evaluating drug-free remission with abatacept in early rheumatoid arthritis: results from the phase 3b, multicentre, randomised, active-controlled AVERT study of 24 months, with a 12-month, double-blind treatment period. Annals of the rheumatic diseases. 2014 Academic Article GET IT
Times cited: 183
Detecting the earliest signs of rheumatoid arthritis: symptoms and examination. Rheumatic diseases clinics of North America. 2014 Review GET IT
Times cited: 8
Preclinical rheumatic disease. Rheumatic diseases clinics of North America. 2014 Article GET IT
Times cited: 1
Earlier time to remission predicts sustained clinical remission in early rheumatoid arthritis--results from the Canadian Early Arthritis Cohort (CATCH). The Journal of rheumatology. 2014 Academic Article GET IT
Times cited: 40
Prognosis of seronegative patients in a large prospective cohort of patients with early inflammatory arthritis. The Journal of rheumatology. 2014 Academic Article GET IT
Times cited: 59
Adding a "GRADE" to the quality appraisal of rheumatoid arthritis guidelines identifies limitations beyond AGREE-II. Journal of clinical epidemiology. 2014 Academic Article GET IT
Times cited: 17
Serum 14-3-3η is a novel marker that complements current serological measurements to enhance detection of patients with rheumatoid arthritis. The Journal of rheumatology. 2014 Academic Article GET IT
Times cited: 65
Are there differences between young- and older-onset early inflammatory arthritis and do these impact outcomes? An analysis from the CATCH cohort. Rheumatology (Oxford, England). 2014 Review GET IT
Times cited: 34
RFC1 80G>A is a genetic determinant of methotrexate efficacy in rheumatoid arthritis: a human genome epidemiologic review and meta-analysis of observational studies. Arthritis & rheumatology (Hoboken, N.J.). 2014 Review GET IT
Times cited: 39
Establishing a core domain set to measure rheumatoid arthritis flares: report of the OMERACT 11 RA flare Workshop. The Journal of rheumatology. 2014 Review GET IT
Times cited: 62
Flares in rheumatoid arthritis: frequency and management. A report from the BRASS registry. The Journal of rheumatology. 2013 Academic Article GET IT
Times cited: 43
Physician global assessment at 3 months is strongly predictive of remission at 12 months in early rheumatoid arthritis: results from the CATCH cohort. Rheumatology (Oxford, England). 2013 Academic Article GET IT
Times cited: 7
Prophylaxis for latent tuberculosis infection prior to anti–tumor necrosis factor therapy in low-risk elderly patients with rheumatoid arthritis: a decision analysis. Arthritis care & research. 2013 Academic Article GET IT
Times cited: 13
Update on the safety profile of certolizumab pegol in rheumatoid arthritis: an integrated analysis from clinical trials. Annals of the rheumatic diseases. 2013 Review GET IT
Times cited: 68
Early rheumatoid arthritis: the performance of the 2010 ACR/EULAR criteria for diagnosing RA. Best practice & research. Clinical rheumatology. 2013 Review GET IT
Times cited: 45
Determining best practices in early rheumatoid arthritis by comparing differences in treatment at sites in the Canadian Early Arthritis Cohort. The Journal of rheumatology. 2013 Academic Article GET IT
Times cited: 26
Factors associated with time to diagnosis in early rheumatoid arthritis. Rheumatology international. 2013 Academic Article GET IT
Times cited: 14
The Relationship Between Function and Disease Activity as Measured by the HAQ and DAS28 Varies Over Time and by Rheumatoid Factor Status in Early Inflammatory Arthritis (EIA). Results from the CATCH Cohort. The open rheumatology journal. 2013 Academic Article GET IT
Times cited: 13
A parallel group cohort to determine the measurement properties of an early inflammatory arthritis detection tool. Rheumatology (Oxford, England). 2013 Academic Article GET IT
Times cited: 7
Each year 1/1000 people develop RA. Preface. Best practice & research. Clinical rheumatology. 2013 Article GET IT
Imaging of rheumatoid arthritis. Rheumatic diseases clinics of North America. 2013 Review GET IT
Times cited: 7
Validation of OMERACT preliminary rheumatoid arthritis flare domains in the NOR-DMARD study. Annals of the rheumatic diseases. 2013 Academic Article GET IT
Times cited: 21
Treatment strategies for early rheumatoid arthritis. Current opinion in rheumatology. 2013 Review GET IT
Times cited: 8
Achieving remission in clinical practice: lessons from clinical trial data. Clinical and experimental rheumatology. 2013 Review GET IT
Times cited: 18
A systematic literature review of strategies promoting early referral and reducing delays in the diagnosis and management of inflammatory arthritis. Postgraduate medical journal. 2013 Academic Article GET IT
Times cited: 19
Anticitrullinated protein antibodies and rheumatoid factor fluctuate in early inflammatory arthritis and do not predict clinical outcomes. The Journal of rheumatology. 2013 Academic Article GET IT
Times cited: 34
Validation of a self-administered inflammatory arthritis detection tool for rheumatology triage. The Journal of rheumatology. 2013 Academic Article GET IT
Times cited: 10
Non-biologic disease-modifying antirheumatic drugs (DMARDs) improve pain in inflammatory arthritis (IA): a systematic literature review of randomized controlled trials. Rheumatology international. 2013 Review GET IT
Times cited: 20
The new ACR/EULAR classification criteria for RA: how are the new criteria performing in the clinic?. Rheumatology (Oxford, England). 2012 Review GET IT
Times cited: 21
The new ACR/EULAR remission criteria: rationale for developing new criteria for remission. Rheumatology (Oxford, England). 2012 Review GET IT
Times cited: 45
Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions. Annals of the rheumatic diseases. 2012 Conference Paper GET IT
Times cited: 99
Increasing treatment in early rheumatoid arthritis is not determined by the disease activity score but by physician global assessment: results from the CATCH study. The Journal of rheumatology. 2012 Academic Article GET IT
Times cited: 15
The Canadian Early Arthritis Cohort (CATCH): patients with new-onset synovitis meeting the 2010 ACR/EULAR classification criteria but not the 1987 ACR classification criteria present with less severe disease activity. The Journal of rheumatology. 2012 Academic Article GET IT
Times cited: 42
Time to disease-modifying antirheumatic drug treatment in rheumatoid arthritis and its predictors: a national, multicenter, retrospective cohort. The Journal of rheumatology. 2012 Academic Article GET IT
Times cited: 26
Incidence and predictors of secondary fibromyalgia in an early arthritis cohort. Annals of the rheumatic diseases. 2012 Academic Article GET IT
Times cited: 59
Identifying core domains to assess flare in rheumatoid arthritis: an OMERACT international patient and provider combined Delphi consensus. Annals of the rheumatic diseases. 2012 Conference Paper GET IT
Times cited: 111
Canadian Rheumatology Association recommendations for the pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs: part II safety. 2012 GET IT
Times cited: 113
Tocilizumab in patients with active rheumatoid arthritis and inadequate responses to DMARDs and/or TNF inhibitors: a large, open-label study close to clinical practice. Annals of the rheumatic diseases. 2012 Academic Article GET IT
Times cited: 87
Quality assurance study of the use of preventative therapies in glucocorticoid-induced osteoporosis in early inflammatory arthritis: results from the CATCH cohort. Rheumatology (Oxford, England). 2012 Academic Article GET IT
Times cited: 39
A systematic literature review of strategies promoting early referral and reducing delays in the diagnosis and management of inflammatory arthritis. Annals of the rheumatic diseases. 2012 Review GET IT
Times cited: 83
Remission in early rheumatoid arthritis -- a comparison of new ACR/EULAR remission criteria to established criteria. The Journal of rheumatology. 2012 Academic Article GET IT
Times cited: 34
Sex differences in pain scores and localization in inflammatory arthritis: a systematic review and metaanalysis. The Journal of rheumatology. 2012 Review GET IT
Times cited: 56
Low prevalence of work disability in early inflammatory arthritis (EIA) and early rheumatoid arthritis at enrollment into a multi-site registry: results from the catch cohort. Rheumatology international. 2012 Academic Article GET IT
Times cited: 5
Multinational evidence-based recommendations for pain management by pharmacotherapy in inflammatory arthritis: integrating systematic literature research and expert opinion of a broad panel of rheumatologists in the 3e Initiative. Rheumatology (Oxford, England). 2012 Conference Paper GET IT
Times cited: 69
Sustained rheumatoid arthritis remission is uncommon in clinical practice. Arthritis research & therapy. 2012 Academic Article GET IT
Times cited: 80
Remission and radiographic outcome in rheumatoid arthritis: application of the 2011 ACR/EULAR remission criteria in an observational cohort. Annals of the rheumatic diseases. 2011 Academic Article GET IT
Times cited: 141
Safety and effectiveness of rituximab in patients with rheumatoid arthritis following an inadequate response to 1 prior tumor necrosis factor inhibitor: the RESET Trial. The Journal of rheumatology. 2011 Academic Article GET IT
Times cited: 35
Canadian Rheumatology Association recommendations for pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs. 2011 GET IT
Times cited: 177
Early management of newly diagnosed rheumatoid arthritis by Canadian rheumatologists: a national, multicenter, retrospective cohort. The Journal of rheumatology. 2011 Academic Article GET IT
Times cited: 15
Emerging issues in pharmacological management of rheumatoid arthritis: results of a national needs assessment survey identifying practice variations for the development of Canadian Rheumatology Association clinical practice recommendations. The Journal of rheumatology. 2011 Academic Article GET IT
Times cited: 9
Developing a construct to evaluate flares in rheumatoid arthritis: a conceptual report of the OMERACT RA Flare Definition Working Group. The Journal of rheumatology. 2011 Conference Paper GET IT
Times cited: 52
Identifying preliminary domains to detect and measure rheumatoid arthritis flares: report of the OMERACT 10 RA Flare Workshop. The Journal of rheumatology. 2011 Conference Paper GET IT
Times cited: 40
Canadian recommendations for clinical trials of pharmacologic interventions in rheumatoid arthritis: inclusion criteria and study design. The Journal of rheumatology. 2011 Review GET IT
Times cited: 11
All that glitters is not gold--standardizing diagnosis in rheumatoid arthritis studies. The Journal of rheumatology. 2011 Editorial Article GET IT
Rheumatoid arthritis: 2011 remission criteria are a new benchmark for RA therapy. Nature reviews. Rheumatology. 2011 Article GET IT
Times cited: 10
Utility and feasibility of musculoskeletal ultrasonography (MSK US) in rheumatology practice in Canada: needs assessment. Clinical rheumatology. 2011 Academic Article GET IT
Times cited: 14
Algorithm for identification of undifferentiated peripheral inflammatory arthritis: a multinational collaboration through the 3e initiative. The Journal of rheumatology. Supplement. 2011 Review GET IT
Times cited: 9
Strategies to prevent rheumatoid arthritis in high-risk patients. Current opinion in rheumatology. 2011 Review GET IT
Times cited: 10
Levamisole-induced retiform purpura. 2011 GET IT
Times cited: 11
Delay in receiving rheumatology care leads to long-term harm. Arthritis and rheumatism. 2010 Editorial Article GET IT
Times cited: 49
Classification of rheumatologic opinion on early inflammatory arthritis: harmonization of a heterogeneous standard. Arthritis care & research. 2010 Review GET IT
Times cited: 5
2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis and rheumatism. 2010 Academic Article GET IT
Times cited: 5878
2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Annals of the rheumatic diseases. 2010 Academic Article GET IT
Times cited: 2568
The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: Phase 2 methodological report. Arthritis and rheumatism. 2010 Conference Paper GET IT
Times cited: 241
The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: methodological report phase I. Annals of the rheumatic diseases. 2010 Review GET IT
Times cited: 137
Multinational evidence-based recommendations on how to investigate and follow-up undifferentiated peripheral inflammatory arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative. Annals of the rheumatic diseases. 2010 Conference Paper GET IT
Times cited: 46
Care gap in patients with early inflammatory arthritis with a high fracture risk identified using FRAX(®). The Journal of rheumatology. 2010 Academic Article GET IT
Times cited: 20
Lack of seroconversion of rheumatoid factor and anti-cyclic citrullinated peptide in patients with early inflammatory arthritis: a systematic literature review. Rheumatology (Oxford, England). 2010 Review GET IT
Times cited: 44
Canadian recommendations for use of methotrexate in patients with rheumatoid arthritis. The Journal of rheumatology. 2010 Review GET IT
Times cited: 33
Efficacy of initial methotrexate monotherapy versus combination therapy with a biological agent in early rheumatoid arthritis: a meta-analysis of clinical and radiographic remission. Annals of the rheumatic diseases. 2010 Review GET IT
Times cited: 59
Development of a self-administered early inflammatory arthritis detection tool. BMC musculoskeletal disorders. 2010 Academic Article GET IT
Times cited: 30
When does rheumatoid arthritis start and can it be stopped before it does?. Annals of the rheumatic diseases. 2010 Editorial Article GET IT
Times cited: 13
Fibrocyte activation in rheumatoid arthritis. Rheumatology (Oxford, England). 2009 Academic Article GET IT
Times cited: 55
Multiparameter phospho-flow analysis of lymphocytes in early rheumatoid arthritis: implications for diagnosis and monitoring drug therapy. PloS one. 2009 Academic Article GET IT
Times cited: 27
Anti-cyclic citrullinated peptide antibody versus HAQ/MDHAQ: comparing apples and oranges?. The Journal of rheumatology. 2009 Editorial Article GET IT
Times cited: 1
Proposal for levels of evidence schema for validation of a soluble biomarker reflecting damage endpoints in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis, and recommendations for study design. The Journal of rheumatology. 2009 Conference Paper GET IT
Times cited: 33
Reappraisal of OMERACT 8 draft validation criteria for a soluble biomarker reflecting structural damage endpoints in rheumatoid arthritis, psoriatic arthritis, and spondyloarthritis: the OMERACT 9 v2 criteria. The Journal of rheumatology. 2009 Conference Paper GET IT
Times cited: 38
Testing of the OMERACT 8 draft validation criteria for a soluble biomarker reflecting structural damage in rheumatoid arthritis: a systematic literature search on 5 candidate biomarkers. The Journal of rheumatology. 2009 Review GET IT
Times cited: 15
Unmet needs in rheumatoid arthritis. The Journal of rheumatology. Supplement. 2009 Review GET IT
Times cited: 17
CTLA4/ICOS gene variants and haplotypes are associated with rheumatoid arthritis and primary biliary cirrhosis in the Canadian population. Arthritis and rheumatism. 2009 Academic Article GET IT
Times cited: 59
Validation of a prediction rule for development of rheumatoid arthritis in patients with early undifferentiated arthritis. Annals of the rheumatic diseases. 2008 Academic Article GET IT
Times cited: 44
Smoldering rheumatoid arthritis: is the Canadian healthcare system neglecting a significant disease population?. The Journal of rheumatology. 2008 Academic Article GET IT
Times cited: 5
Adalimumab for early rheumatoid arthritis. Expert review of clinical immunology. 2008 Academic Article GET IT
Times cited: 2
Are the 2002 American College of Rheumatology guidelines for the management of rheumatoid arthritis being followed in Canada's largest academic rheumatology center?. The Journal of rheumatology. 2007 Academic Article GET IT
Times cited: 9
The Canadian Rheumatology Association/ Spondyloarthritis Research Consortium of Canada treatment recommendations for the management of spondyloarthritis: a national multidisciplinary stakeholder project. The Journal of rheumatology. 2007 Conference Paper GET IT
Times cited: 42
Distinctive gene expression signatures in rheumatoid arthritis synovial tissue fibroblast cells: correlates with disease activity. Genes and immunity. 2007 Academic Article GET IT
Times cited: 76
Etanercept in the treatment of rheumatoid arthritis. Therapeutics and clinical risk management. 2007 Academic Article GET IT
Times cited: 48
Rheumatoid arthritis association with the FCRL3 -169C polymorphism is restricted to PTPN22 1858T-homozygous individuals in a Canadian population. Arthritis and rheumatism. 2006 Academic Article GET IT
Times cited: 52
Access to care for rheumatology patients may be compromised: results of a survey to members of the Canadian Rheumatology Association. The Journal of rheumatology. 2005 Editorial Article GET IT
Times cited: 3
What are the goals and principles of management in the early treatment of rheumatoid arthritis?. Best practice & research. Clinical rheumatology. 2005 Review GET IT
Times cited: 20
Infusion-related reactions to infliximab in patients with rheumatoid arthritis in a clinical practice setting: relationship to dose, antihistamine pretreatment, and infusion number. The Journal of rheumatology. 2004 Academic Article GET IT
Times cited: 71
Rheumatoid arthritis: is the disease becoming milder or is treatment improving?. The Journal of rheumatology. 2004 Editorial Article GET IT
Times cited: 8
Intraarticular corticosteroids, supervised physiotherapy, or a combination of the two in the treatment of adhesive capsulitis of the shoulder: a placebo-controlled trial. Arthritis and rheumatism. 2003 Academic Article GET IT
Times cited: 301
Role of adalimumab in the treatment of early rheumatoid arthritis. Clinical and experimental rheumatology. 2003 Academic Article GET IT
Times cited: 25
Role of infliximab in the treatment of early rheumatoid arthritis. Clinical and experimental rheumatology. 2003 Review GET IT
Times cited: 14
Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia. A randomized, double-blind clinical trial. Arthritis and rheumatism. 1994 Academic Article GET IT
Times cited: 329
Systemic vasculitis following influenza vaccination--report of 3 cases and literature review. The Journal of rheumatology. 1993 Review GET IT
Times cited: 86
Low-dose methotrexate with leucovorin (folinic acid) in the management of rheumatoid arthritis. Results of a multicenter randomized, double-blind, placebo-controlled trial. Arthritis and rheumatism. 1993 Academic Article GET IT
Times cited: 136
Hydroxychloroquine in systemic lupus erythematosus. The New England journal of medicine. 1991 Letter GET IT
Times cited: 1
A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus. The New England journal of medicine. 1991 Academic Article GET IT
Times cited: 590
The seal finger: an unusual case of monoarticular sepsis. 1986 GET IT
Times cited: 8

more ...

less ...

Background

education and training

M.D., McMaster University, Faculty of Medicine (Canada) 1981
B.Sc., McMaster University (Canada) 1978

Contact

full name

Vivian Patricia Bykerk

primary email

vpb9002@med.cornell.edu

webpage

Clinical Profile

VIVO Weill Cornell Medical College

Vivian Patricia Bykerk Professor of Medicine

Publications

selected publications

Background

education and training

Contact

full name

primary email

webpage

Phone

Publications

selected publications

Background

education and training

Contact

full name

primary email

webpage